FIGURE

Fig. 1

ID
ZDB-FIG-240916-126
Publication
Zhong et al., 2024 - Functional Insights in PLS3-Mediated Osteogenic Regulation
Other Figures
All Figure Page
Back to All Figure Page
Fig. 1

Actinin-1 and Actinin-4 rescue malformation of craniofacial bone structure, body axis, and tail in 5-day-old col1a1:eGFP zebrafish with pls3 morpholino (pls3 MO). (A) Overview of different observed phenotypes of developing skeletal elements in col1α1:eGFP fish (cartilage green) with and without pls3 MO knockdown. Phenotype is subdivided into three different types of severity: (I) normal: all structures are present and developed normally; (II) malformed: m, ch, and pq are shorter and partially malformed; (III) severely malformed: m, ch, and pq are shorter and partially malformed, some cb are absent. (m: Meckel’s cartilage; ch: ceratohyal; pq: palatoquadrate; cb: ceratobranchial). (B) Statistical analysis of phenotypes of control fish compared to knockdown and rescue fish. Control fish show 100% normal skull development, which is significantly reduced to 10.11% in 0.8 mM pls3 MO-treated fish (p < 0.0001). This effect is rescued by co-injection of 300 pg human PLS3, ACTN1, and ACTN4 mRNA (61.43%, 45.90%, and 42.30% normal skull, respectively, compared to pls3 MO: p < 0.0001). Co-injection of FSCN1 mRNA showed 22.72% normal skull development compared to pls3 MO: p = 0.1105. (C) Analysis of body axis form with exemplary pictures for categorization. Control fish show 98.44% normal body axis, which is significantly reduced to 24.32% in 8 mM pls3 MO-treated fish (p < 0.0001). This effect is rescued by co-injection of 300 pg human PLS3, ACTN1, ACTN4, and FSCN1 mRNA (66.28%, 52.87%, 58.47%, and 50.55% normal body axis, respectively, compared to pls3 MO: p < 0.0001). (D) Analysis of tail form with exemplary pictures for categorization. Control fish show 100% normal tail, which is significantly reduced to 52.43% in 0.8 mM pls3 MO-treated fish (p < 0.0001). This effect is rescued by co-injection of 300 pg human PLS3, ACTN1, and ACTN4 mRNA (86.05%, 65.52%, and 72.68% normal tail, respectively, compared to pls3 MO: p < 0.0001, p < 0.05, p < 0.001, and p < 0.001). Co-injection of FSCN1 mRNA only showed 31.87% normal tail compared to pls3 MO: p < 0.001 (for every experimental set-up, n > 50; scale bar = 100 μm).

Expression Data
Gene:
Fish:
Knockdown Reagent:
Anatomical Terms:
Stage: Day 5

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Knockdown Reagent:
Observed In:
Stage: Day 5

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells